Trio Pharmaceuticals

About:

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

Website: https://www.triopharmaceuticals.com/

Top Investors: Tech Coast Angels, Purdue Foundry, SeedFolio, Friedman BioVentures, Newsight Tech Angels

Description:

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.

Total Funding Amount:

$3.73M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-05-25

Contact Email:

shiva(AT)triopharmaceuticals.com

Founders:

Reiner Laus, Shiva Bhowmik

Number of Employees:

1-10

Last Funding Date:

2023-03-28

IPO Status:

Private

Industries: